Location
Headquarters: Franklin Lakes, New Jersey, United States, North America
Region: New Jersey
Country: US
Continent: North America
About
BD is a global leader in medical technology focused on advancing the world of health through innovative medical products, capabilities, and solutions. The company operates worldwide, offering products and services across healthcare settings including laboratories, medication delivery, patient safety, and surgical solutions. BD emphasizes improving safety, efficiency, and outcomes in healthcare systems through its diverse portfolio and research-driven approach. It is headquartered and operates across multiple regions, with a strong presence in the United Kingdom and other international markets.
BD is a global medical technology company that develops and manufactures medical devices, diagnostic systems, and medication delivery products. Its customers include hospitals, laboratories, and healthcare providers worldwide, utilizing BD's solutions to improve patient safety, clinical efficiency, and disease detection.
Medicon Co., Ltd
1897
for_profit
active
Industries
Primary Industry: Manufacturing
Categories
Funding & Financials
Public Company
24000000
over-1b
ipo
NYSE:BDX
nasdaq
Investors
Founders
Fairleigh Dickinson
Maxwell Becton
Leadership
Raphael Lozano — Principal Mechanical Engineer
Richard Byrd — Executive Vice President and President of the BD Interventional Segment
Marco Salerno — IDS EU Solution Manager
Shana Neal — Chief People Officer
Michael Garrison — Executive Vice President and President of the BD Medical segment
Simon Campion — Executive Vice President & President, Medical Segment
Technology Stack
Products
BD Vascular Access Management (VAM): A system for managing vascular access devices to support infusion therapy and patient care.
Rotarex™ Atherectomy System: A medical device used to remove arterial blockages in peripheral artery disease treatment.
BD COR™ System: A molecular diagnostic system designed to meet evolving laboratory needs for pathogen detection.
Smart Connect Care Solutions: A portfolio of advanced monitoring technologies for critical care and hemodynamic management.
Funding rounds
Post Ipo Equity · $540M · (2023-08-02) · Lead: Steris
IPO · (1962-04-23)